Reshma Rangwala - Apr 19, 2022 Form 3 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Signature
/s/Nancy Smith, Attorney-in-Fact for Reshma Rangwala
Stock symbol
KPTI
Transactions as of
Apr 19, 2022
Transactions value $
$0
Form type
3
Date filed
4/29/2022, 08:45 AM
Previous filing
Jan 25, 2022
Next filing
May 2, 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.